Global Needle Free Drug Delivery Devices Market Research and Analysis 2015-2022

Market Insights:

The Global needle free drug delivery devices Market is expected to grow at a modest CAGR of 16.7% during 2017-2022. The Needle free drug delivery technology is a most innovative technique to deliver drugs into a person's body without piercing their skin. The market is growing at a very fast majorly due to rising geriatric population, technological advancement and so on. The rising need for self-administration of drugs as in the case of diseases like diabetes and pain-free drug delivery have consequentially enhanced the industry share of global needle-free drug delivery devices. Furthermore, controlled dosing ability, rapid drug administration and minimal damage to skin are the key associated benefits boosting the physician preference thereby fueling the demand for the global market. Additionally, the increasing focus on the growth of portable delivery devices has a positive, high impact on the needle-free drug delivery devices market globally. These aforesaid advantages related to needle-free drug delivery devices are anticipated to serve as key boasting factors spurring the growth of the global needle-free drug delivery devices market over the forecast period.

On the other hand, low awareness regarding needle free technology and high development cost of needle-free injection systems over the conventional needle injection may act as a roadblock in the growth of this market during the forecast period. The report includes detailed Market Overview, Analyst Insights and predictive analysis, Market Determinants, Market Segmentation, Geographical Analysis, Strategic Recommendations, Key Company Analysis, Key Findings, Market Insights and Company Profiling.

Geographical Insights:

Global needle free drug delivery devices Market is regionally segmented into North America, Europe, Asia Pacific and Rest of the world. North American region dominates the global market, this region held the largest revenue share of the global Needle Free drug delivery devices market in 2016. This can be attributed majorly due to the increasing prevalence of chronic diseases, , high awareness pertaining to novel drug delivery systems among the patient base, development of biologics and pharmaceutical drugs and devices and an increasing number of R&D investments by prominent market players domiciled in this region.

The Asia Pacific region is anticipated to witness lucrative growth opportunities in the upcoming future, growing at a CAGR of approx. 16.0% during the forecast period. This is a consequence of the increasing elderly population requiring home-based, Needle Free drug delivery devices for enhanced mobility, and the rising healthcare disbursement in emerging economies such as India and China.

Competitive Insights:

The Key Players In The Global needle free drug delivery devices Market Include 3 M, AkraDermojetInc, Antares Pharma Inc., Bayer Ag, Bioject Medical Technologies, Inc., GlaxosmithklinPlc, Glide Pharmaceutical Technologies Ltd., InjexPharma Ag, Jdrf, Johnson & Johnson, Inc., Medtronic, Inc., Merck And Co., Nemera, Novartis Ag, PancreumLlc, Pfizer, Inc., Pharmajet, Inc., Sanofi, Tandem Diabetes Care, Inc., Zogenix, Inc. And so on Partnership, R&D, M&A, Product Launch Are the Key Strategy Adopted In The global needle free drug delivery devices Market.

Market Segmentation:

Global needle free drug delivery devices Market is segmented on the basis of technology, applications, end users and regional outlook. On the basis of technology market is divided into Oral drug delivery system, Inhaler technology, Laser based needle free injectors, Jet injectors, Novel needle free technologies, spring based needle free injectors, Transdermal patch technology and other needle free technology. The Jet injectors is having the largest market share and is dominating the technology segment in 2016, majorly due to its high usage rate and extensive applicability in delivering a large range of drugs.

1. Global Needle Free Drug Delivery Devices Market Research and Analysis, By Technology

• 1.1. Oral Drug Delivery System
• 1.2. Inhaler Technology
• 1.3. Laser Based Needle Free Injectors
• 1.4. Jet Injectors
• 1.5. Novel Needle Free Technologies
• 1.6. Spring Based Needle Free Injectors
• 1.7. Transdermal Patch Technology
• 1.8. Other Needle Free Technology

2. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS, BY APPLICATION

• 2.1. Pain management
• 2.2. Insulin delivery for diabetes
• 2.3. Vaccine delivery
• 2.4. Pediatric injections
• 2.5. Obstructive sleep apnea
• 2.6. Other applications
• 2.7. Hypertension
• 2.8. Angina
• 2.9. Other medical conditions

3. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS, BY END USER

• 3.1. HOSPITALS
• 3.2. HOME HEALTHCARES
• 3.3. CLINICS
• 3.4. OTHERS

4. Global needle free drug delivery devices Market Research And Analysis, By Region

• 4.1. North America
• 4.2. Europe
• 4.3. APAC
• 4.4. RoW

OMR Report covers:

• Comprehensive research methodology of Global needle free drug delivery devices Market.
• This report also includes detailed and extensive market overview with key analyst insights.
• Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Global needle free drug delivery devices Market.
• Insights about market determinants which are stimulating the Global needle free drug delivery devices Market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.

Table of Contents

1. REPORT SUMMARY

• 1.1. RESEARCH METHODS AND TOOLS
• 1.2. MARKET BREAKDOWN
  • 1.2.1. BY SEGMENTS
  • 1.2.2. BY GEOGRAPHY
  • 1.2.3. BY STAKEHOLDERS
  • 1.2.4. EXCEPTIONS

2. MARKET OVERVIEW AND INSIGHTS

• 2.1. DEFINITION
• 2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
  • 2.2.1. KEY FINDINGS
  • 2.2.2. RECOMMENDATION
  • 2.2.3. CONCLUSION
• 2.3. RAW MATERIAL ANALYSIS
• 2.4. REGULATION
  • 2.4.1.1. UNITED STATES
  • 2.4.1.2. EUROPEAN UNION
  • 2.4.1.3. CHINA
  • 2.4.1.4. INDIA

3. MARKET DETERMINANT

• 3.1. MOTIVATORS
  • 3.1.1. BENEFITS OVER CONVENTIONAL DRUG DELIVERY DEVICES
  • 3.1.2. RISING INCIDENCES OF RESPIRATORY DISEASES
  • 3.1.3. TECHNOLOGICAL ADVANCEMENTS
  • 3.1.4. RISE IN CONSTRUCTION INDUSTRIES STIMULATING THE GLOBAL NEEDLE FREE DRUG DELIVERY DEVICES MARKET
• 3.2. RESTRAINT
  • 3.2.1. COMPLEX REGULATORY FRAMEWORK
  • 3.2.2. HIGH PRICES
  • 3.2.3. LOW AWARENESS
• 3.3. OPPORTUNITY
  • 3.3.1. GROWING ASIA PACIFIC REGION 

4. MARKET SEGMENTATION

• 4.1. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS, BY TECHNOLOGY
  • 4.1.1. ORAL DRUG DELIVERY SYSTEM
  • 4.1.2. INHALER TECHNOLOGY
  • 4.1.3. LASER BASED NEEDLE FREE INJECTORS
  • 4.1.4. JET INJECTORS
  • 4.1.5. NOVEL NEEDLE FREE TECHNOLOGIES
  • 4.1.6. SPRING BASED NEEDLE FREE INJECTORS
  • 4.1.7. TRANSDERMAL PATCH TECHNOLOGY
  • 4.1.8. OTHER NEEDLE FREE TECHNOLOGY
• 4.2. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS, BY APPLICATION
  • 4.2.1. PAIN MANAGEMENT
  • 4.2.2. INSULIN DELIVERY FOR DIABETES
  • 4.2.3. VACCINE DELIVERY
  • 4.2.4. PAEDIATRIC INJECTIONS
  • 4.2.5. OBSTRUCTIVE SLEEP APNEA
  • 4.2.6. OTHER APPLICATIONS
    • 4.2.6.1. HYPERTENSION
    • 4.2.6.2. ANGINA
    • 4.2.6.3. OTHER MEDICAL CONDITIONS
• 4.3. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS, BY END USER
  • 4.3.1. HOSPITALS
  • 4.3.2. HOME HEALTHCARES
  • 4.3.3. CLINICS
  • 4.3.4. OTHERS

5. COMPETITIVE LANDSCAPE

• 5.1. KEY STRATEGIES
• 5.2. KEY COMPANY ANALYSIS

6. REGIONAL ANALYSIS

• 6.1. NORTH AMERICA
  • 6.1.1. UNITED STATES
  • 6.1.2. CANADA
• 6.2. EUROPE
  • 6.2.1. UK
  • 6.2.2. GERMANY
  • 6.2.3. SPAIN
  • 6.2.4. FRANCE
  • 6.2.5. ITALY
  • 6.2.6. ROE
• 6.3. ASIA PACIFIC
  • 6.3.1. INDIA
  • 6.3.2. CHINA
  • 6.3.3. JAPAN
  • 6.3.4. ROAPAC
• 6.4. REST OF THE WORLD

7. COMPANY PROFILES

• 7.1. 3 M
  • 7.1.1. INTRODUCTION
  • 7.1.2. 3 M PRODUCT PORTFOLIO
  • 7.1.3. 3 M RECENT ACTIVITIES
• 7.2. AKRA DERMOJET INC
  • 7.2.1. INTRODUCTION
  • 7.2.2. AKRA DERMOJET INC PRODUCT PORTFOLIO
  • 7.2.3. AKRA DERMOJET INC ZO NOBEL NV RECENT ACTIVITIES
• 7.3. ANTARES PHARMA INC.
  • 7.3.1. INTRODUCTION
  • 7.3.2. ANTARES PHARMA INC.PRODUCT PORTFOLIO
  • 7.3.3. ANTARES PHARMA INC. RECENT ACTIVITIES
• 7.4. BAYER AG
  • 7.4.1. INTRODUCTION
  • 7.4.2. BAYER AG PRODUCT PORTFOLIO
  • 7.4.3. BAYER AG RECENT ACTIVITIES
• 7.5. BIOJECT MEDICAL TECHNOLOGIES, INC.
  • 7.5.1. INTRODUCTION
  • 7.5.2. BIOJECT MEDICAL TECHNOLOGIES, INC. PRODUCT PORTFOLIO
  • 7.5.3. BIOJECT MEDICAL TECHNOLOGIES, INC. RECENT ACTIVITIES
• 7.6. GLAXOSMITHKLIN PLC
  • 7.6.1. INTRODUCTION
  • 7.6.2. GLAXOSMITHKLIN PLC PRODUCT PORTFOLIO
  • 7.6.3. GLAXOSMITHKLIN PLC RECENT ACTIVITIES
• 7.7. GLIDE PHARMACEUTICAL TECHNOLOGIES LTD.
  • 7.7.1. INTRODUCTION
  • 7.7.2. GLIDE PHARMACEUTICAL TECHNOLOGIES LTD. PRODUCT PORTFOLIO
  • 7.7.3. GLIDE PHARMACEUTICAL TECHNOLOGIES LTD. RECENT ACTIVITIES
• 7.8. INJEX PHARMA AG
  • 7.8.1. INTRODUCTION
  • 7.8.2. INJEX PHARMA AG PRODUCTS AND CHEMICALS PRODUCT PORTFOLIO
  • 7.8.3. INJEX PHARMA AG RECENT ACTIVITIES
• 7.9. JDRF
  • 7.9.1. INTRODUCTION
  • 7.9.2. JDRF PRODUCT PORTFOLIO
  • 7.9.3. JDRF RECENT ACTIVITIES
• 7.10. JOHNSON & JOHNSON, INC.
  • 7.10.1. INTRODUCTION
  • 7.10.2. JOHNSON & JOHNSON, INC. PRODUCT PORTFOLIO
  • 7.10.3. JOHNSON & JOHNSON, INC. COMPANY RECENT ACTIVITIES
• 7.11. MEDTRONIC, INC.
  • 7.11.1. INTRODUCTION
  • 7.11.2. MEDTRONIC, INC. PRODUCT PORTFOLIO
  • 7.11.3. MEDTRONIC, INC. RECENT ACTIVITIES
• 7.12. MERCK AND CO.
  • 7.12.1. INTRODUCTION
  • 7.12.2. MERCK AND CO. PRODUCT PORTFOLIO
  • 7.12.3. MERCK AND CO. RECENT ACTIVITIES
• 7.13. NEMERA
  • 7.13.1. INTRODUCTION
  • 7.13.2. NEMERA PRODUCT PORTFOLIO
  • 7.13.3. NEMERA RECENT ACTIVITIES
• 7.14. NOVARTIS AG
  • 7.14.1. INTRODUCTION
  • 7.14.2. NOVARTIS AG PRODUCT PORTFOLIO
  • 7.14.3. NOVARTIS AG RECENT ACTIVITIES
• 7.15. PANCREUM LLC
  • 7.15.1. INTRODUCTION
  • 7.15.2. PANCREUM LLC PRODUCT PORTFOLIO
  • 7.15.3. PANCREUM LLC RECENT ACTIVITIES
• 7.16. PFIZER, INC.
  • 7.16.1. INTRODUCTION
  • 7.16.2. PFIZER, INC. PRODUCT PORTFOLIO
  • 7.16.3. PFIZER, INC. RECENT ACTIVITIES
• 7.17. PHARMAJET, INC.
  • 7.17.1. INTRODUCTION
  • 7.17.2. PHARMAJET, INC. PRODUCT PORTFOLIO
  • 7.17.3. PHARMAJET, INC. RECENT ACTIVITIES
• 7.18. SANOFI
  • 7.18.1. INTRODUCTION
  • 7.18.2. SANOFI PRODUCT PORTFOLIO
  • 7.18.3. SANOFI RECENT ACTIVITIES
• 7.19. TANDEM DIABETES CARE, INC.
  • 7.19.1. INTRODUCTION
  • 7.19.2. TANDEM DIABETES CARE, INC. PRODUCT PORTFOLIO
  • 7.19.3. TANDEM DIABETES CARE, INC. RECENT ACTIVITIES
• 7.20. ZOGENIX, INC.
  • 7.20.1. INTRODUCTION
  • 7.20.2. ZOGENIX, INC. PRODUCT PORTFOLIO
  • 7.20.3. ZOGENIX, INC. RECENT ACTIVITIES

List of Tables

• TABLE # 1 GLOBAL NEEDLE FREE DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS, BY TECHNOLOGY 2015-2022 ($MILLION)
• TABLE # 2 ORAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• TABLE # 3 INHALER TECHNOLOGY MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• TABLE # 4 LASER BASED NEEDLE FREE INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• TABLE # 5 JET INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• TABLE # 6 NOVEL NEEDLE FREE TECHNOLOGIES MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• TABLE # 7 SPRING BASED NEEDLE FREE INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• TABLE # 8 TRANSDERMAL PATCH TECHNOLOGY MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• TABLE # 9 OTHER NEEDLE FREE TECHNOLOGY MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• TABLE # 10 GLOBAL NEEDLE FREE DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2015-2022 ($MILLION)
• TABLE # 11 PAIN MANAGEMENT MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• TABLE # 12 INSULIN DELIVERY FOR DIABETES MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• TABLE # 13 VACCINE DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• TABLE # 14 PAEDIATRIC INJECTIONS MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• TABLE # 15 OBSTRUCTIVE SLEEP APNEA MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• TABLE # 16 OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• TABLE # 17 HYPERTENSION MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• TABLE # 18 ANGINA MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• TABLE # 19 OTHER MEDICAL CONDITIONS MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• TABLE # 20 GLOBAL NEEDLE FREE DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS, BY END USER 2015-2022 ($MILLION)
• TABLE # 21 HOSPITALS MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• TABLE # 22 HOME HEALTHCARES MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• TABLE # 23 CLINICS MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• TABLE # 24 OTHERS MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• TABLE # 25 3 M PRODUCT PORTFOLIO
• TABLE # 26 3 M RECENT ACTIVITIES
• TABLE # 27 AKRA DERMOJET INC PRODUCT PORTFOLIO
• TABLE # 28 AKRA DERMOJET INC ZO NOBEL NV RECENT ACTIVITIES
• TABLE # 29 ANTARES PHARMA INC.PRODUCT PORTFOLIO
• TABLE # 30 ANTARES PHARMA INC. RECENT ACTIVITIES
• TABLE # 31 BAYER AG PRODUCT PORTFOLIO
• TABLE # 32 BAYER AG RECENT ACTIVITIES
• TABLE # 33 BIOJECT MEDICAL TECHNOLOGIES, INC. PRODUCT PORTFOLIO
• TABLE # 34 BIOJECT MEDICAL TECHNOLOGIES, INC. RECENT ACTIVITIES
• TABLE # 35 GLAXOSMITHKLIN PLC PRODUCT PORTFOLIO
• TABLE # 36 GLAXOSMITHKLIN PLC RECENT ACTIVITIES
• TABLE # 37 GLIDE PHARMACEUTICAL TECHNOLOGIES LTD. PRODUCT PORTFOLIO
• TABLE # 38 GLIDE PHARMACEUTICAL TECHNOLOGIES LTD. RECENT ACTIVITIES
• TABLE # 39 INJEX PHARMA AG PRODUCTS AND CHEMICALS PRODUCT PORTFOLIO
• TABLE # 40 INJEX PHARMA AG RECENT ACTIVITIES
• TABLE # 41 JDRF PRODUCT PORTFOLIO
• TABLE # 42 JDRF RECENT ACTIVITIES
• TABLE # 43 JOHNSON & JOHNSON, INC. PRODUCT PORTFOLIO
• TABLE # 44 JOHNSON & JOHNSON, INC. COMPANY RECENT ACTIVITIES
• TABLE # 45 MEDTRONIC, INC. PRODUCT PORTFOLIO
• TABLE # 46 MEDTRONIC, INC. RECENT ACTIVITIES
• TABLE # 47 MERCK AND CO. PRODUCT PORTFOLIO
• TABLE # 48 MERCK AND CO. RECENT ACTIVITIES
• TABLE # 49 NEMERA PRODUCT PORTFOLIO
• TABLE # 50 NEMERA RECENT ACTIVITIES
• TABLE # 51 NOVARTIS AG PRODUCT PORTFOLIO
• TABLE # 52 NOVARTIS AG RECENT ACTIVITIES
• TABLE # 53 PANCREUM LLC PRODUCT PORTFOLIO
• TABLE # 54 PANCREUM LLC RECENT ACTIVITIES
• TABLE # 55 PFIZER, INC. PRODUCT PORTFOLIO
• TABLE # 56 PFIZER, INC. RECENT ACTIVITIES
• TABLE # 57 PHARMAJET, INC. PRODUCT PORTFOLIO
• TABLE # 58 PHARMAJET, INC. RECENT ACTIVITIES
• TABLE # 59 SANOFI PRODUCT PORTFOLIO
• TABLE # 60 SANOFI RECENT ACTIVITIES
• TABLE # 61 TANDEM DIABETES CARE, INC. PRODUCT PORTFOLIO
• TABLE # 62 TANDEM DIABETES CARE, INC. RECENT ACTIVITIES
• TABLE # 63 ZOGENIX, INC. PRODUCT PORTFOLIO
• TABLE # 64 ZOGENIX, INC. RECENT ACTIVITIES

List of Figures

• FIGURE # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• FIGURE # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• FIGURE # 3 CANADA MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• FIGURE # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• FIGURE # 5 UK MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• FIGURE # 6 GERMANY MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• FIGURE # 7 SPAIN MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• FIGURE # 8 FRANCE MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• FIGURE # 9 ITALY MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• FIGURE # 10 ROE MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• FIGURE # 11 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• FIGURE # 12 INDIA MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• FIGURE # 13 CHINA MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• FIGURE # 14 JAPAN MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• FIGURE # 15 ROPAC MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)
• FIGURE # 16 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS 2015-2022 ($MILLION)